Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot. (2022)
Attributed to:
Oesophago-gastric adenocarcinoma: understanding disease pathogenesis and applications to earlier diagnosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(21)00667-7
PubMed Identifier: 35030332
Publication URI: http://europepmc.org/abstract/MED/35030332
Type: Journal Article/Review
Volume: 23
Parent Publication: The Lancet. Oncology
Issue: 2
ISSN: 1470-2045